Furthermore, the release of IL-6 activates the C/EBP signaling pathway, leading to CCL20 expression in cancer-associated fibroblasts and TH17 recruitment, which promote tumor progression and angiogenesis (Figure 2C) [91]. This evidence concerns the gene IL6 and cancer.